Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 6.110

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	12/29/2004 1:05:48 PM
	Read Replies (1) of 7255

Bio-Rad most likely on the prowl now! HERCULES, Calif., Dec. 13 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (AMEX: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced that it has agreed to sell $200 million aggregate principal amount of its 6 1/8% Senior Subordinated Notes due 2014 in a private offering. The Company intends to close the transaction on December 21, 2004. The Company intends to use the proceeds for working capital and general corporate purposes, which may include acquisitions. biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next